WRBY· Health Care› Medical Instruments & Supplies

Warby Parker Inc. Class A

Stage 3 · Topping · week 7

As of Oct 22, 2026, Warby Parker is in Stage 3, the topping phase, now in week 7 (since Sep 10, 2026). It closed at $25.67, 15.4% below its 52-week high and above its 200-day average, which is rising.

Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. More about the company

$25.67

+0.16% today

$3.2B · Mid cap

Market Neutral — Building

Pro read

Pro

Our read

Topping: the uptrend is tiring

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is WRBY early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S2 20w

S2 14w

S2 13w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S1 3w → S2 3w → S3 5w → S2 3w → S3 4w → S4 4w → S1 1w → S2 7w → S3 6w → S4 2w → S3 1w → S2 12w → S3 10w → S2 20w → S3 6w → S4 6w → S1 5w → S2 14w → S3 5w → S4 5w → S1 1w → S2 9w → S3 3w → S4 5w → S1 4w → S2 13w → S3 6w current

Total tracked: 164 weeks across 27 stage runs.

WRBY among Medical Instruments & Supplies12th of 51 by relative strength

All 51 →

Stocks in Medical Instruments & Supplies ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	PLSEPulse Biosciences, Inc	Stage 2 · wk 34	98	+1.3%
2	PDEXPro-Dex, Inc.	Stage 2 · wk 36	97	−13.3%
3	HBIOHarvard Bioscience, Inc.	Stage 2 · wk 11	95	+3.6%
4	ATRCAtriCure, Inc.	Stage 2 · wk 10	89	−1.1%
5	WSTWest Pharmaceutical Services, Inc.	Stage 2 · wk 24	82	+4.8%
6	BDXBecton, Dickinson and Company	Stage 2 · wk 11	81	+9.8%
7	ICUIICU Medical, Inc.	Stage 3 · wk 1	81	+3.1%
8	OSUROraSure Technologies, Inc.	Stage 3 · wk 8	75	−4.8%
…12	WRBYWarby Parker Inc. Class A	Stage 3 · wk 7	68	+9.9%

vs 52W High

-15.4%

$16.49 lo$30.34 hi

15.4% below 52W high, weakening from peak

The stock is rolling over from its 52-week high. In Stage 3 distribution, new long positions carry high risk.

Stage Maturity

Week 7

1w13w26w

Week 7, distribution

How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.

vs 200 DMA

1.7%

200 DMA: $25.25 · rising

Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.

Rel Volume

0.87x

vs 50-day avg

Volume spikes on down days during Stage 3 signal distribution, with institutions exiting. Stage analysis reads that as a warning against new long positions.

Trend Health

↗ ⇈

Short-term trend rising gently, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+9.9%

+4.5%

+14.3%

YTD

+13.5%

+18.1%

Scan Membership

Breakout Watch

Latest: 2024-10-21

6 appearances in last 60 days. First seen: 2023-01-25.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S3

Wk 7 · Vol 0.87x

2026-10-21S3

Wk 6 · Vol 0.50x

2026-10-20S3

Wk 6 · Vol 0.99x

2026-10-19S3

Wk 6 · Vol 1.52x

2026-10-16S3

Wk 6 · Vol 0.94x

2026-10-15S3

Wk 6 · Vol 1.38x

2026-10-14S3

Wk 5 · Vol 1.03x

2026-10-13S3

Wk 5 · Vol 0.95x

2026-10-12S3

Wk 5 · Vol 0.73x

2026-10-09S3

Wk 5 · Vol 0.52x

2026-10-08S3

Wk 5 · Vol 0.96x

2026-10-07S3

Wk 4 · Vol 0.58x

Moving averages & range

50 DMA

$25.32

200 DMA

$25.25

52W High

$30.34

52W Low

$16.49

5D Low

$23.34

Resistance levels (recent highs)

20d High

$27.78

60d High

$29.92

120d High

$30.34

250d High

$30.34

Next resistance

+8.2%

to 20d High

P/E (TTM)

427.8

Forward 41.8

ROE

+2.1%

Profit margin +0.8%

Dividend Yield

0.00%

P/B 8.1

Warby Parker: quick answers

What stage is Warby Parker in?

As of Oct 22, 2026, Warby Parker (WRBY) is in Stage 3, the topping phase. It entered Stage 3 on Sep 10, 2026 and is in week 7. What the four stages mean

Is Warby Parker in an uptrend?

Its uptrend has stalled. Warby Parker is in Stage 3, the topping phase that follows an advance. It trades 1.7% above its 200-day average, which is rising.

How far is Warby Parker from its 52-week high?

Warby Parker closed at $25.67 on Oct 22, 2026, 15.4% below its 52-week high of $30.34. Its 52-week low is $16.49.

How has Warby Parker performed over the past year?

As of Oct 22, 2026, Warby Parker is up 18.1% over the past year and up 13.5% so far in 2026.

Which sector and industry is Warby Parker in?

Warby Parker is in the Medical Instruments & Supplies industry, part of the Health Care sector.

About this companyHealth Care· Medical Instruments & Supplies

Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses. It also provides accessories, such as cases, pouches, lenses kit with anti-fog spray, travel cases, lenses cloth, anti-fog lens spray, and sun clip-ons through its stores, website, and mobile apps. In addition, the company offers eye exams and vision tests, as well as optical services. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.